ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

NUVB Panacea Acquisition Corp

3,20
0,21 (7,02%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:34:03
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Panacea Acquisition Corp NUVB NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
0,21 7,02% 3,20 22:34:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,05 3,005 3,305 3,20 2,99
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202416:01BWNuvation Bio to Present Updated Data on Taletrectinib, a..
10.4.202422:01BWNuvation Bio Completes Acquisition of AnHeart Therapeutics
28.3.202413:00BWNuvation Bio Announces Appointment of Colleen Sjogren as..
25.3.202412:00BWNuvation Bio to Acquire AnHeart Therapeutics in All-Stock..
14.3.202421:05BWNuvation Bio Doses First Patient in Phase 1/2 Study of..
04.3.202423:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
04.3.202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202422:48EDGAR2Form 8-K - Current report
29.2.202422:01BWNuvation Bio Reports Fourth Quarter and Full Year 2023..
10.1.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
08.1.202422:58DJNNuvation Bio Gets New Drug Application Clearance From FDA..
08.1.202422:17EDGAR2Form 8-K - Current report
08.1.202422:10BWNuvation Bio Announces Appointment of Dr. Robert Mashal to..
08.1.202422:05BWNuvation Bio Announces FDA Clearance of Investigational New..
14.12.202322:02EDGAR2Form 8-K - Current report
27.11.202322:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
27.11.202322:01EDGAR2Form 8-K - Current report
13.11.202322:11EDGAR2Form 8-K - Current report
13.11.202322:05BWNuvation Bio Announces Departure of Chief Financial Officer
02.11.202321:23EDGAR2Form 8-K - Current report
02.11.202321:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:10BWNuvation Bio Reports Third Quarter 2023 Financial Results..
03.8.202323:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.8.202322:17EDGAR2Form 8-K - Current report
03.8.202322:10BWNuvation Bio Reports Second Quarter 2023 Financial Results..
01.6.202322:05BWNuvation Bio Announces Formation of Oncology-Focused..
04.5.202322:05BWNuvation Bio Reports First Quarter 2023 Financial Results..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock